Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

NisinvsThymalin

FDA GRAS-approved lantibiotic (34 amino acids) produced by Lactococcus lactis with a dual antimicrobial mechanism — binds lipid II to block cell wall synthesis AND forms 2 nm transmembrane pores for rapid bacterial killing at MIC 0.5-4 μg/mL against gram-positive pathogens including MRSA and Listeria monocytogenes — the only antimicrobial peptide with over 50 years of documented safe human consumption

Russian thymic peptide complex that rejuvenates immune function and supports healthy aging

ImmuneImmune

At a Glance

Quick
comparison

Dose Range

Nisin

2.5–25 mg/kg (food preservation; ADI 0.13 mg/kg BW)

Thymalin

5–10 mg

Frequency

Nisin

Once daily

Thymalin

Once daily

Administration

Nisin

Oral (food-grade preservative, GRAS)

Thymalin

Intramuscular injection

Cycle Length

Nisin

Ongoing/indefinite

Thymalin

4-6 weeks

Onset Speed

Nisin

Rapid (hours to days)

Thymalin

Moderate (1-2 weeks)

Evidence Level

Nisin

Strong human trials (Phase 3 or FDA approved)

Thymalin

Limited human trials

Efficacy

Benefit
ratings

Nisin
Thymalin

Immune

Nisin9%
Thymalin0%

Healing & Recovery

Nisin7%
Thymalin0%

Anti-Aging

Nisin5%
Thymalin0%

Immune Restoration

Nisin0%
Thymalin88%

Longevity Support

Nisin0%
Thymalin82%

Disease Prevention

Nisin0%
Thymalin78%

Technical Data

Compound
specifications

Nisin

Molecular Formula

C143H230N42O37S7

Molecular Weight

3,354.12 Da

Half-Life

Rapidly degraded in GI tract by digestive proteases; stable for hours to days in food matrices at acidic pH; lanthionine ring structures resist most environmental proteases; thermostable (survives pasteurization)

Bioavailability

Degraded by pancreatic proteases in GI tract (does not affect gut microbiome at dietary levels); topical application achieves effective local concentrations; optimal activity at pH 2-6; lanthionine bridges provide significant protease resistance compared to linear peptides

CAS Number

1414-45-5

Thymalin

Molecular Formula

Complex mixture; active dipeptide EW: C16H19N3O5

Molecular Weight

Polypeptide complex; components 250-1000 Da; active dipeptide EW ~321 Da

Half-Life

Not precisely characterized for complex; immune effects persist weeks post-administration

Bioavailability

High via intramuscular or subcutaneous injection

CAS Number

63958-90-7

Protocols

Dosing
tiers

Nisin

starting

2.5-5 mg/kg (food preservation standard)

Single application during food processing

Provides antimicrobial protection throughout product shelf life

Standard food preservation concentration used in commercial dairy products, canned foods, and processed meats. At these levels, nisin is highly effective against Listeria monocytogenes and Clostridium species. This is the well-established, FDA GRAS application with decades of safety data. Optimal activity at pH 2-6.

standard

10-50 μg/mL (research topical application)

Once or twice daily in research settings

Research protocol-dependent (typically 1-4 weeks)

Research concentration for topical antimicrobial applications including wound care models, dental applications, and antimicrobial coating development. Effective against gram-positive skin and wound pathogens including MRSA at these concentrations. Can be combined with EDTA or polymyxin to extend gram-negative coverage.

advanced

50-200 μg/mL (research applications)

Protocol-dependent

Research protocol-dependent

Higher research concentrations for anti-biofilm studies, anticancer research, and synergy studies with gram-negative-targeting agents. At 200 μg/mL combined with EDTA, nisin provides gram-negative coverage. Anticancer IC50 against MCF-7 is approximately 12 μg/mL. Medical supervision required for any non-food applications.

Thymalin

starting

5 mg daily

Once daily

5 days

Initial dose to assess tolerance and immune response; best for first-time users

standard

10 mg daily

Once daily

10 days

Standard clinical protocol used in most Russian research studies; most effective dose

advanced

10 mg Thymalin + 5 mg Epitalon daily

Once daily

20 days, repeated every 6 months

Combined peptide protocol for enhanced longevity and geroprotective effects

Applications

Best
suited for

Nisin

Food preservation as a natural antimicrobial alternative to chemical preservatives

Nisin is particularly well-suited for individuals focused on food preservation as a natural antimicrobial alternative to chemical preservatives. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Research into novel antimicrobial therapeutics based on lantibiotic scaffolds

Nisin is particularly well-suited for individuals focused on research into novel antimicrobial therapeutics based on lantibiotic scaffolds. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Anti-Listeria and anti-Clostridium strategies in food safety and clinical settings

Nisin is particularly well-suited for individuals focused on anti-listeria and anti-clostridium strategies in food safety and clinical settings. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Development of antimicrobial wound dressings and dental applications

Nisin is particularly well-suited for individuals focused on development of antimicrobial wound dressings and dental applications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Thymalin

Aging Adults Seeking Immune Support

Thymalin is especially valuable for people over 55 whose thymus gland has naturally shrunk with age. By stimulating thymic function, it helps restore the immune training center that your body relies on to fight infections and stay healthy.

Longevity and Anti-Aging Protocols

Clinical studies tracking patients for 6-8 years showed Thymalin reduced mortality by 2.0-2.1-fold. Combined with Epitalon, the mortality reduction reached an impressive 4.1-fold, making this combination one of the most studied longevity peptide protocols.

Seasonal Illness Prevention

Research shows Thymalin cuts respiratory infection rates by 2.0-2.4-fold. A short 10-day course before cold and flu season can significantly boost your immune defenses for months afterward.

Safety Profile

Side
effects

Nisin

Common

  • No significant effects at dietary levels
  • Mild GI discomfort at research doses
  • Local irritation (topical use)

Uncommon

  • Milk protein allergic reaction
  • Gram-negative overgrowth

Serious

  • No documented serious adverse effects

Thymalin

Common

  • No side effects in most patients
  • Mild injection site reaction

Uncommon

  • Transient low-grade fever
  • Mild flu-like symptoms
  • Temporary headache

Serious

  • Severe allergic reaction

Research Status

Safety
& evidence

Nisin

Evidence Level

Strong human trials (Phase 3 or FDA approved)

FDA Status

FDA approved for this use

Safety Overview

Nisin holds FDA GRAS status since 1988 with over 50 years of documented safe human consumption, making it the only antimicrobial peptide with this comprehensive long-term safety record. Oral LD50 of 174 mg/kg in mice (comparable to table salt) demonstrates extraordinary safety margin. Acceptable daily intake established at 0.13 mg/kg body weight with no reported serious adverse events at this or higher levels. Primary risk is milk protein contamination during production, requiring screening for lactose-intolerant or milk-allergic individuals.

Contraindications

  • xKnown hypersensitivity to nisin or Lactococcus lactis-derived products
  • xMilk protein allergy — nisin production involves dairy-associated bacteria and preparations may contain trace milk proteins
  • xPregnancy and breastfeeding at therapeutic (non-dietary) doses — standard dietary exposure through preserved foods is considered safe
  • xActive inflammatory bowel disease — potential for local irritation at high oral concentrations exceeding normal dietary levels

Thymalin

Evidence Level

Limited human trials

FDA Status

Research compound

Safety Overview

Thymalin has an excellent safety profile based on over 40 years of clinical use in Russia. Most patients experience zero side effects, and the peptide complex has been described as 'practically non-toxic' in research literature. It has been used safely in thousands of patients, including elderly populations over extended periods.

Contraindications

  • xActive thymic tumors or malignancies
  • xKnown hypersensitivity to animal-derived peptide products
  • xPregnancy and breastfeeding (insufficient safety data)
  • xSevere uncontrolled autoimmune disease without medical supervision

Decision Guide

Which is
right for you?

Choose Nisin if...

  • Food preservation as a natural antimicrobial alternative to chemical preservatives
  • Research into novel antimicrobial therapeutics based on lantibiotic scaffolds
  • Anti-Listeria and anti-Clostridium strategies in food safety and clinical settings
  • Development of antimicrobial wound dressings and dental applications

Choose Thymalin if...

  • Immune system restoration in aging adults
  • Longevity and healthy aging support
  • Reducing infection frequency and severity
  • Multi-system health optimization